Lenacapavir: a transformative advance in HIV therapy and prevention-promise, access, and equity in Africa
{{output}}
Lenacapavir is a first-in-class HIV capsid inhibitor with a long-acting formulation that enables twice-yearly dosing for both treatment and prevention. Its novel mechanism and extended dosing interval represent a paradigm shift in HIV care. Sub-Saharan Africa ... ...
